首页> 外文期刊>Neuro-Oncology >CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone
【24h】

CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone

机译:CXCL12介导胶质母细胞瘤对脑室下区域的放射治疗耐药

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Patients with glioblastoma (GBM) have an overall median survival of 15 months despite multimodal therapy. These catastrophic survival rates are to be correlated to systematic relapses that might arise from remaining glioblastoma stem cells (GSCs) left behind after surgery. In this line, it has recently been demonstrated that GSCs are able to escape the tumor mass and preferentially colonize the adult subventricular zone (SVZ). At a distance from the initial tumor site, these GSCs might therefore represent a high-quality model of clinical resilience to therapy and cancer relapses as they specifically retain tumor-initiating abilities.
机译:背景。尽管采取了多模式疗法,但胶质母细胞瘤(GBM)患者的总中位生存期为15个月。这些灾难性的存活率与手术后遗留的剩余胶质母细胞瘤干细胞(GSC)可能引起的系统性复发相关。在这方面,最近已证明GSC能够逃脱肿瘤块并优先定居于成人脑室下区域(SVZ)。这些GSC在距原始肿瘤部位一定距离的地方,因此可以代表临床对治疗的适应能力和癌症复发的高质量模型,因为它们特别保留了肿瘤引发能力。

著录项

  • 来源
    《Neuro-Oncology》 |2017年第1期|66-77|共12页
  • 作者单位

    Univ Liege, GIGA Neurosci Res Ctr, Dev Neurobiol Lab, Liege, Belgium|Univ Liege, Liege, Belgium|CHU Liege, Human Genet, Liege, Belgium|Univ Med Ctr, Dept Neurosurg, Brain Ctr Rudolf Magnus, Inst Neurosci, Utrecht, Netherlands|Univ Med Ctr, T&P Bohnenn Lab Neurooncol, Utrecht, Netherlands;

    Univ Liege, GIGA Neurosci Res Ctr, Dev Neurobiol Lab, Liege, Belgium|CHU Liege, Dept Neurosurg, Liege, Belgium|Univ Liege, Liege, Belgium;

    Univ Liege, Liege, Belgium|CHU Liege, Dept Radiotherapy & Oncol, Liege, Belgium|Univ Liege, GIGA Canc Res Ctr, Lab Tumor & Dev Biol, Liege, Belgium|Univ Liege, Cyclotron Res Ctr, Liege, Belgium;

    Univ Liege, Liege, Belgium|CHU Liege, Human Genet, Liege, Belgium|Univ Med Ctr, Dept Neurosurg, Brain Ctr Rudolf Magnus, Inst Neurosci, Utrecht, Netherlands|Univ Med Ctr, T&P Bohnenn Lab Neurooncol, Utrecht, Netherlands;

    Univ Liege, GIGA Neurosci Res Ctr, Dev Neurobiol Lab, Liege, Belgium;

    Univ Liege, GIGA Viral Vector Plateform, Liege, Belgium;

    Univ Med Ctr, Dept Neurosurg, Brain Ctr Rudolf Magnus, Inst Neurosci, Utrecht, Netherlands|Univ Med Ctr, T&P Bohnenn Lab Neurooncol, Utrecht, Netherlands;

    Univ Liege, GIGA Neurosci Res Ctr, Dev Neurobiol Lab, Liege, Belgium;

    Univ Liege, GIGA Neurosci Res Ctr, Dev Neurobiol Lab, Liege, Belgium;

    Univ Med Ctr, Dept Neurosurg, Brain Ctr Rudolf Magnus, Inst Neurosci, Utrecht, Netherlands|Univ Med Ctr, T&P Bohnenn Lab Neurooncol, Utrecht, Netherlands;

    Univ Liege, Liege, Belgium|CHU Liege, Human Genet, Liege, Belgium;

    CHU Liege, Dept Neurosurg, Liege, Belgium|Univ Liege, Liege, Belgium;

    Univ Liege, Liege, Belgium|CHU Liege, Dept Radiotherapy & Oncol, Liege, Belgium;

    Univ Liege, Liege, Belgium|CHU Liege, Dept Neurol, Liege, Belgium;

    Univ Liege, GIGA Neurosci Res Ctr, Dev Neurobiol Lab, Liege, Belgium|Univ Liege, Liege, Belgium|CHU Liege, Dept Neurol, Liege, Belgium;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    CXCL12; glioblastoma; mesenchymal activation; radioresistance; subventricular zone;

    机译:CXCL12;胶质母细胞瘤;间质激活;放射电阻;心室下区;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号